Current Progress in the Pharmacogenetics of Infectious Disease Therapy
作者： E Elliot , T Mahungu , A Owen , None
DOI: 10.1016/B978-0-12-799942-5.00019-6
关键词:
摘要: … to correlate the degree of hyperlipidemia with the number of unfavorable polymorphisms. In … 183 Quinine is metabolized by CYP3A isoforms to its primary metabolite, 3-hydroxyquinine. …
sci-hub.se 参考文章(223)
Magnus Ingelman-Sundberg, Stefan Lundgren, Filip Josephson, Lars Ståhle, Anders Sönnerborg, Jue Wang, Anders Rane, Identification of a novel specific CYP2B6 allele in Africans causing impaired metabolism of the HIV drug efavirenz. Pharmacogenetics and Genomics. ,vol. 16, pp. 191- 198 ,(2006) , 10.1097/01.FPC.0000189797.03845.90
Zhan S, Sun F, Chen Y, Xiang Y, Drug-metabolising enzyme polymorphisms and predisposition to anti-tuberculosis drug-induced liver injury: a meta-analysis. International Journal of Tuberculosis and Lung Disease. ,vol. 12, pp. 994- 1002 ,(2008)
Bunnag D, Evans Da, Fletcher Ka, Greaves J, Harinasuta T, Gilles Hm, Studies on the pharmacokinetics of primaquine. Bulletin of The World Health Organization. ,vol. 59, pp. 407- 412 ,(1981)
Heather J Ribaudo, Catia Marzolini, Todd Hulgan, David B Clifford, Richard B Kim, Edward P Acosta, Roy M Gulick, David W Haas, Camlin Tierney, Grant R Wilkinson, Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study. AIDS. ,vol. 18, pp. 2391- 2400 ,(2004)
Bernhard Setzer, Ulrich A Walker, Anna K Thomas, Michael Schlesier, Mitochondrial toxicity of nucleoside analogues in primary human lymphocytes. Antiviral Therapy. ,vol. 10, pp. 327- 334 ,(2005)
Elke Störmer, Lisa L. von Moltke, Michael D. Perloff, David J. Greenblatt, Differential modulation of P-glycoprotein expression and activity by non-nucleoside HIV-1 reverse transcriptase inhibitors in cell culture. Pharmaceutical Research. ,vol. 19, pp. 1038- 1045 ,(2002) , 10.1023/A:1016430825740
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration The Lancet. ,vol. 371, pp. 1417- 1426 ,(2008) , 10.1016/S0140-6736(08)60423-7
Antonio Aceti, Pharmacogenetics as a tool to tailor antiretroviral therapy: A review World journal of virology. ,vol. 4, pp. 198- 208 ,(2015) , 10.5501/WJV.V4.I3.198
Anthony Wood, Duncan Armour, The discovery of the CCR5 receptor antagonist, UK-427,857, a new agent for the treatment of HIV infection and AIDS. Progress in Medicinal Chemistry. ,vol. 43, pp. 239- 271 ,(2005) , 10.1016/S0079-6468(05)43007-6
I. Cavaco, R. Piedade, M. I. Msellem, A. Bjorkman, J. P. Gil, Cytochrome 1A1 and 1B1 gene diversity in the Zanzibar islands. Tropical Medicine & International Health. ,vol. 17, pp. 854- 857 ,(2012) , 10.1111/J.1365-3156.2012.03011.X